Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advanced renal pelvis carcinoma patient with an ERBB2 insertion mutation: a case report.

The Journal of international medical research - 1 Nov 2023

Shang Peipei, Lou Cheng, Yin Lei, Tao Chenjie, Dong Yulong, Yang Guang, Yuan Zhengang

Abstract excerpt

The prognosis of renal pelvis cancer is poor and therapeutic options are limited, especially for patients with advanced disease. In this report, we present a case of advanced renal pelvis carcinoma in a male patient in his 60s, characterized by an activating mutation in ERBB2. Clinical evaluation resulted in a pathological diagnosis of renal pelvis carcinoma with liver metastasis. Immunohistochemistry staining...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Kidney Neoplasms
Share to Mutagenesis, Insertional

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Neoplasm Recurrence, Local

Share to Receptor, ErbB-2

Share to Trastuzumab

Source

Open in PubMed Open full text

Identifiers

PMID: 37917812
DOI: 10.1177/03000605231204502
PMCID: PMC10623987

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advanced renal pelvis carcinoma patient with an ERBB2 insertion mutation: a case report.PMID 37917812Read ↗

Primary mucinous tumors of the renal pelvis: Clinical, histopathological, and molecular analysis of three cases.Semantic proximity Read ↗

Gastric metastasis of renal cell carcinoma and molecular targeted therapy: a case reportSemantic proximity Read ↗

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Semantic proximity Read ↗

The Evolving Story of Renal Translocation CarcinomasSemantic proximity Read ↗

ATR and BRCA2 Simultaneous Mutation in a ccRCC With Sarcomatoid Differentiation and Extensive Metastases: A Case Report.Semantic proximity Read ↗

Case report: Long-term survival with anlotinib in a metastatic parathyroid carcinoma patient harboring EGFR-sensitizing mutationSemantic proximity Read ↗

Discovery of Novel Potential Prognostic Marker and Targeted Therapy to Overcome Chemotherapy Resistance in an Advanced Stage Wilms’ TumorSemantic proximity Read ↗

Pembrolizumab combined with Axitinib in ASPSCR1-TFE3 gene fusion translocation renal cell carcinoma: a case report and literature reviewSemantic proximity Read ↗

Somatic mutation in the ACK1 ubiquitin association domain enhances oncogenic signaling through EGFR regulation in renal cancer derived cells.Semantic proximity Read ↗

Renal carcinoma associated with succinate dehydrogenase B mutation: a new and unique subtype of renal carcinoma.Semantic proximity Read ↗

High-Throughput Functional Evaluation of Variants of Unknown Significance in ERBB2.Semantic proximity Read ↗

Long-term survival in a patient with metastatic parathyroid carcinoma harboring an EGFR sensitizing mutation: a case report.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.